Despite its high incidence and mortality rate, the molecular mechanism
s underlying the oncogenesis and progression of prostate cancer are st
ill unclear. This review, based on recently published data, surveys th
e current state of knowledge of human prostate oncogenesis, dealing wi
th genetic predisposition in familial clusters of prostate cancer, pro
viding new information on the somatic genetic alterations, which have
been approached in four ways (measurement of DNA content, cytogenetic
analysis, in situ hybridization, and molecular analysis), and investig
ating the problems of androgen independence and intratumour heterogene
ity in prostate tumours. Lastly, the potential clinical applications o
f the genetic alterations, which may become important in the near futu
re, are addressed.